Plasmodium falciparum gametocyte surface protein P230 (Pfs230)

Plasmodium falciparum gametocyte surface protein P230 (Pfs230) is a large (>300 kDa), multi-domain protein of the 6-cysteine family expressed on the surface of sexual stage parasites (gametocytes and gametes) of Plasmodium falciparum, the cause of the most harmful form of human malaria[2][1][5]. Pfs230 is involved in male/female gamete fusion, male gamete exflagellation, and interaction with host erythrocytes, all of which are key steps in parasite fertilization and subsequent transmission to the mosquito[2][6][7]. It does not have a known membrane anchor but forms a membrane-bound complex on gametes, often together with another protein, Pfs48/45[3][4][5]. Knockout studies confirm its essentiality for parasite fertility and transmission, making it a leading candidate for malaria transmission-blocking vaccines. Monoclonal or polyclonal antibodies targeting Pfs230, especially domains with conserved transmission-blocking epitopes, can inhibit parasite development in the mosquito and thus block transmission[3][4][5]. There are no approved small molecule drugs directly targeting Pfs230, but it is the focus of numerous vaccine strategies.

Other names

Gametocyte surface protein P230Sexual stage antigen P230Ps230

Antibodies blocking Pfs230 inhibit parasite fertility and transmission by interfering with gamete fusion or complex formation on gamete surfaces